Suppr超能文献

一项旨在减少慢性危重症患者再次入院率的疾病管理项目试验。

Trial of a disease management program to reduce hospital readmissions of the chronically critically ill.

作者信息

Daly Barbara J, Douglas Sara L, Kelley Carol Genet, O'toole Elizabeth, Montenegro Hugo

机构信息

School of Nursing, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH 44106-4904, USA.

出版信息

Chest. 2005 Aug;128(2):507-17. doi: 10.1378/chest.128.2.507.

Abstract

BACKGROUND

Patients requiring prolonged periods of intensive care and mechanical ventilation are termed chronically critically ill. They are prone to continued morbidity and mortality after hospital discharge and are at high risk for hospital readmission. Disease management (DM) programs have been shown to be effective in improving both coordination and efficiency of care after hospital discharge for populations with single-disease diagnoses, but have not been tested with patients with multiple-disease diagnoses, such as the chronically critically ill.

STUDY OBJECTIVES

To test the effect of a DM program on hospital readmission patterns of chronically critically ill patients during the first 2 months after hospital discharge and to estimate the cost-effectiveness of the DM program.

DESIGN

Randomized, controlled trial.

SETTING

Academic medical center, extended care facilities, and participant homes.

PARTICIPANTS

Three hundred thirty-four consenting adults from one academic medical center who underwent > 3 days of mechanical ventilation and survived to hospital discharge.

INTERVENTION

Two hundred thirty-one patients in the experimental group received care coordination, family support, teaching, and monitoring of therapies from a team of advanced-practice nurses, a geriatrician, and a pulmonologist for 2 months post-hospital discharge.

MEASUREMENTS

Rehospitalization rate, time-to-first rehospitalization, duration of rehospitalization, mortality during rehospitalization, and associated costs.

RESULTS

Patients who received DM services had significantly fewer mean days of rehospitalization (11.4; 95% confidence interval [CI], 9.3 to 12.6) compared with the control group (16.7 days; 95% CI, 12.5 to 21.0; p = 0.03). There were no other significant differences between experimental and control groups, although all measures of rehospitalization risk for the experimental group were in a positive direction. Total cost savings associated with the intervention were approximately $481,811 for the 93 subjects who were readmitted to the hospital.

CONCLUSIONS

Chronic critical illness may have a natural trajectory of continued morbidity following hospital discharge that is not affected by the provision of additional care coordination services. Nevertheless, given the high cost of rehospitalization and the additional burden it imposes on patients and families, interventions that can reduce the duration of rehospitalization are cost-effective and merit continued testing.

摘要

背景

需要长时间重症监护和机械通气的患者被称为慢性危重症患者。他们在出院后仍有持续发病和死亡的倾向,且再次入院风险很高。疾病管理(DM)项目已被证明对于改善单病种诊断人群出院后的护理协调和效率是有效的,但尚未在慢性危重症等多病种诊断患者中进行测试。

研究目的

测试DM项目对慢性危重症患者出院后头2个月内再次入院模式的影响,并评估DM项目的成本效益。

设计

随机对照试验。

地点

学术医疗中心、长期护理机构和参与者家中。

参与者

来自一个学术医疗中心的334名同意参与的成年人,他们接受了超过3天的机械通气并存活至出院。

干预措施

实验组的231名患者在出院后2个月内接受了由高级执业护士、老年病专家和肺科医生组成的团队提供的护理协调、家庭支持、教学和治疗监测。

测量指标

再住院率、首次再住院时间、再住院时长、再住院期间的死亡率以及相关成本。

结果

与对照组(16.7天;95%置信区间[CI],12.5至21.0;p = 0.03)相比,接受DM服务的患者平均再住院天数显著更少(11.4天;95% CI,9.3至12.6)。实验组和对照组之间没有其他显著差异,尽管实验组所有再住院风险指标都呈正向趋势。对于93名再次入院的受试者,与干预相关的总成本节省约为481,811美元。

结论

慢性危重症在出院后可能有持续发病的自然病程,不受额外护理协调服务的影响。然而,鉴于再住院成本高昂及其给患者和家庭带来的额外负担,能够减少再住院时长的干预措施具有成本效益,值得继续测试。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验